XML 57 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Equity Compensation Plans and Equity (Details 2) (USD $)
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Restricted Stock and Restricted Stock Units
     
Restricted stock awards including restricted stock units, Shares      
Nonvested at the beginning of the period (in shares) 618,000    
Granted (in shares) 324,000    
Vested (in shares) (167,000)    
Forfeited (including cancelled awards) (in shares) (82,000)    
Nonvested at the end of the period (in shares) 693,000    
Weighted-Average Grant-Date Fair Value      
Nonvested at the beginning of the period (in dollars per share) $ 33.61    
Granted (in dollars per share) $ 32.62    
Vested (in dollars per share) $ 20.60    
Forfeited (including cancelled awards) (in dollars per share) $ 34.98    
Nonvested at the end of the period (in dollars per share) $ 36.11    
Stock options
     
Stock option awards, Shares      
Outstanding at the beginning of the period (in shares) 2,106,000    
Granted (in shares) 704,000    
Exercised (in shares) (351,000)    
Forfeited (including cancelled options) (in shares) (137,000)    
Outstanding at the end of the period (in shares) 2,322,000 2,106,000  
Options exercisable at the end of the period (in shares) 1,282,000    
Weighted Average Exercise price      
Outstanding at the beginning of the period (in dollars per share) $ 25.58    
Granted (in dollars per share) $ 32.55    
Exercised (in dollars per share) $ 15.39    
Forfeited (including cancelled options) (in dollars per share) $ 35.88    
Outstanding at the end of the period (in dollars per share) $ 28.63 $ 25.58  
Options exercisable at the end of the period (in dollars per share) $ 22.63    
Aggregate Intrinsic Value      
Outstanding at the end of the period (in dollars) $ 13,149,000    
Options exercisable at the end of the period (in dollars) 12,948,000    
Weighted Average Remaining Contractual Life      
Outstanding at the end of the period 6 years 4 months 24 days    
Options exercisable at the end of the period 4 years 6 months    
Other disclosures      
Weighted-average grant date fair value (in dollars per share) $ 15.56 $ 21.90 $ 18.41
Total intrinsic value of stock options exercised $ 6,800,000 $ 22,800,000 $ 53,100,000